Literature DB >> 33423597

Drosophila melanogaster: a fruitful model for oncohistones.

Amel Chaouch1, Paul Lasko1,2.   

Abstract

Drosophila melanogaster has proven to be a powerful genetic model to study human disease. Approximately 75% of human disease-associated genes have homologs in the fruit fly and regulatory pathways are highly conserved in Drosophila compared to humans. Drosophila is an established model organism for the study of genetics and developmental biology related to human disease and has also made a great contribution to epigenetic research. Many key factors that regulate chromatin condensation through effects on histone post-translational modifications were first discovered in genetic screens in Drosophila. Recently, the importance of chromatin regulators in cancer progression has been uncovered, leading to a rapid expansion in the knowledge on how perturbations of chromatin can result in the pathogenesis of human cancer. In this review, we provide examples of how Drosophila melanogaster has contributed to better understanding the detrimental effects of mutant forms of histones, called 'oncohistones', that are found in different human tumours.

Entities:  

Keywords:  Oncohistones; PcG proteins; chromatin; epigenetics

Mesh:

Substances:

Year:  2021        PMID: 33423597      PMCID: PMC7808415          DOI: 10.1080/19336934.2020.1863124

Source DB:  PubMed          Journal:  Fly (Austin)        ISSN: 1933-6934            Impact factor:   2.160


  60 in total

1.  Hierarchical recruitment of polycomb group silencing complexes.

Authors:  Liangjun Wang; J Lesley Brown; Ru Cao; Yi Zhang; Judith A Kassis; Richard S Jones
Journal:  Mol Cell       Date:  2004-06-04       Impact factor: 17.970

2.  Role of histone H2A ubiquitination in Polycomb silencing.

Authors:  Hengbin Wang; Liangjun Wang; Hediye Erdjument-Bromage; Miguel Vidal; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Nature       Date:  2004-09-22       Impact factor: 49.962

Review 3.  Polycomb response elements and targeting of Polycomb group proteins in Drosophila.

Authors:  Jürg Müller; Judith A Kassis
Journal:  Curr Opin Genet Dev       Date:  2006-08-17       Impact factor: 5.578

4.  Ash1 counteracts Polycomb repression independent of histone H3 lysine 36 methylation.

Authors:  Eshagh Dorafshan; Tatyana G Kahn; Alexander Glotov; Mikhail Savitsky; Matthias Walther; Gunter Reuter; Yuri B Schwartz
Journal:  EMBO Rep       Date:  2019-03-04       Impact factor: 8.807

Review 5.  Chromatin plasticity: A versatile landscape that underlies cell fate and identity.

Authors:  Tejas Yadav; Jean-Pierre Quivy; Geneviève Almouzni
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

6.  Targeted in situ genome-wide profiling with high efficiency for low cell numbers.

Authors:  Peter J Skene; Jorja G Henikoff; Steven Henikoff
Journal:  Nat Protoc       Date:  2018-04-12       Impact factor: 13.491

7.  Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.

Authors:  Leilei Shi; Jiejun Shi; Xiaobing Shi; Wei Li; Hong Wen
Journal:  J Mol Biol       Date:  2018-04-22       Impact factor: 5.469

8.  Recognizing methylated histone variant H3.3 to prevent tumors.

Authors:  Swaminathan Venkatesh; Jerry L Workman
Journal:  Cell Res       Date:  2014-04-15       Impact factor: 25.617

9.  Interrogating the function of metazoan histones using engineered gene clusters.

Authors:  Daniel J McKay; Stephen Klusza; Taylor J R Penke; Michael P Meers; Kaitlin P Curry; Stephen L McDaniel; Pamela Y Malek; Stephen W Cooper; Deirdre C Tatomer; Jason D Lieb; Brian D Strahl; Robert J Duronio; A Gregory Matera
Journal:  Dev Cell       Date:  2015-02-09       Impact factor: 12.270

10.  Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation.

Authors:  Neil P Blackledge; Anca M Farcas; Takashi Kondo; Hamish W King; Joanna F McGouran; Lars L P Hanssen; Shinsuke Ito; Sarah Cooper; Kaori Kondo; Yoko Koseki; Tomoyuki Ishikura; Hannah K Long; Thomas W Sheahan; Neil Brockdorff; Benedikt M Kessler; Haruhiko Koseki; Robert J Klose
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.